- Mangoceuticals is launching a $100 million digital asset treasury strategy focused entirely on Solana.
- Cube Group will manage the strategy, targeting annualized SOL staking yields of 7-20% for investors.
Mangoceuticals (MGRX), a telemedicine-focused health and wellness company, has partnered with Cube Group, a digital asset treasury firm, to establish a new digital asset treasury (DAT) strategy with a target capacity of up to $100 million in Solana (SOL), according to a new press release.
Mangoceuticals plans to leverage its Nasdaq listing to raise capital through at-the-market equity offerings to fund the phased accumulation of SOL. The strategy provides investors with a proxy for Solana’s ecosystem growth and institutional-grade DeFi yield strategies.
“This Solana-focused DAT strategy represents a pivotal evolution for Mangoceuticals, blending our commitment to innovation with the immense potential of digital assets,” said Jacob Cohen, founder and CEO of Mangoceuticals.
MGRX has filed a trademark for “MULTI-DAT,” a framework covering virtual currency transactions, fund transfers, portfolio management, and blockchain-based crypto operations.
The initiative includes a Digital Asset Treasury 2.0 strategy with staking, tokenized assets, DeFi infrastructure, and stablecoin treasury tools, starting with actively managed SOL staking targeting 7–20% annualized yields.
“This initiative not only capitalizes on Solana’s superior yield opportunities but also sets a new standard for corporate crypto strategies, paving the way for exponential growth in a rapidly evolving market,” Bartosz Lipinski, Co-Founder and CEO of Cube Group, stated.